PARIS--(Marketwire - April 30, 2009) -
Highlighted Links |
companynewsgroup Home Page |
Paris, April 29, 2009 - Cegedim, the world's leading CRM provider for the pharmaceutical industry, announces that its 2008 reference Documents has been published in compliance with the " Autorité des Marchés Financiers " (AMF) on April 28th, 2009 under the number D.09-0331. This report is available for free at the headquarters of the Company (Cegedim, Financial Department, 137 rue d'Aguesseau, 92100 Boulogne Billancourt) and is also available on the Company's website www.cegedim.com under the heading Investors/Financial Information. An English version will be available on Mai 7th, 2009.
About Cegedim:
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies. The world leader in pharmaceutical CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,200 people in more than 80 countries and generated revenue of EUR 849 million in 2008.
To learn more, please visit our website: www.cegedim.com Listed on NYSE Euronext Paris, compartment B - ISIN FR0000053506 - Reuters CGDM.PA - Bloomberg CGM
This information is provided by HUGIN
Media inquiries
CEGEDIM
Sylvie Delangle
Media Relations
Tel.: + 33 (0)1 49 09 67 73
Email Contact
Presse & Papiers
Guillaume de Chamisso
Attaché de Presse
Tel. : + 33 (0)1 77 35 60 99
Email Contact
Investor relations
CEGEDIM
Jan Eryk Umiastowski
Chief Investment Officer
Tel.: + 33 (0)1 49 09 22 00
Email Contact